The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis

Overview of attention for article published in BMC Cancer, January 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 1 news outlet

twitter: 3 X users

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 33 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,796 followers.

RT @CancerRounds: Capecitabine has been evaluated for early breast #cancertreatment. Although it cannot be used in every case, it does incr…

24 Sep 2022

Reply Repost Favourite

Capecitabine has been evaluated for early breast #cancertreatment. Although it cannot be used in every case, it does increase the 15-year survival rate of an early cancer #patient. Read more on: https://t.co/vfWnarPtKN Consult a #oncologist by contact

24 Sep 2022

Reply Repost Favourite

#BestStudyoftheDay: The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer https://t.co/TINhnhFlmS - BMC Cancer - #breast #cancer #oncology

26 Jan 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.